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Abstract
Background—The dynamic establishment of the nasal microbiota in early life influences local 
mucosal immune responses and the susceptibility to childhood respiratory disorders.
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Objective—The aim of this case-control study was to monitor, evaluate and compare the 
development of the nasal microbiota of infants who developed rhinitis and wheeze in the first 18 
months of life with those of healthy controls.
Methods—Anterior nasal swabs of 122 subjects belonging to the GUSTO birth cohort were 
collected longitudinally over seven time points in the first 18 months of life. The nasal microbiota 
signatures were analyzed using 16S rRNA multiplexed pair-end sequencing from three clinical 
groups (1) rhinitis alone (n=28), (2) rhinitis with concomitant wheeze (n=34) and (3) healthy 
controls (n=60).
Results—The maturation of the nasal microbiome followed distinctive patterns in infants from 
both rhinitis groups compared to controls. Bacterial diversity increased over the period of 18 
months of life in control infants, whilst infants with rhinitis showed a decreasing trend (p<0.05). 
An increase in abundance of Oxalobacteraceae family (Proteobacteria phylum) and Aerococcaceae 
family (Firmicutes phylum) was associated with rhinitis and concomitant wheeze (adj p<0.01) 
whilst Corynebacteriaceae family (Actinobacteria phylum) and early colonization with 
Staphylococcaceae family (Firmicutes phylum) (3 weeks till 9 months) was associated with 
controls (adj p<0.05). The only difference between the rhinitis group and controls was a reduced 
abundance of Corynebacteriaceae family (adj p<0.05). Determinants of nasal microbiota 
succession included gender, mode of delivery, presence of siblings and infant care attendance.
Conclusion—Our results support the hypothesis that nasal microbiome is involved in the 
development of early onset rhinitis and wheeze in infants.
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Introduction
Rhinitis and wheezing disorders in infancy and childhood are common [1, 2]. Birth cohort 
studies, including our “Growing Up in Singapore Towards healthy Outcomes” (GUSTO) 
birth cohort, have described infants and toddlers with persistent and recurrent rhinitis. 
Although the majority do not have allergen sensitization in infancy, early onset rhinitis has 
been associated with eczema, wheeze and parental history of allergic disorders, suggesting 
that atopy may play a role in the manifestation of rhinitis. [3–5]
Considerable current evidence supports bacteria-virus interactions as an important factor in 
lower respiratory tract infections. Respiratory syncytial virus and rhinovirus have been 
implicated as triggers of wheezing disorders in infants and young children, and as predictors 
of subsequent asthma at school age [6–10]. It has also been recognized that the resident 
microbiota of the respiratory tract plays a role as gate keeper that either facilitates or 
provides resistance to colonization by respiratory virus [10, 11]. The presence of several 
potentially pathogenic bacteria such as Moraxella catarrhalis in the airways has been 
associated with asthma and wheeze development [12, 13]. Moreover, farming studies 
support the concept that environmental microbial exposure has a protective effect on the 
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development of allergic disease [14, 15]. This brings up the concept of “exposome” in which 
the health status of an individual is determined by his environmental and lifestyle exposure.
Recently, Bosch et al. identified significant differences in the nasal microbiome profiles in 
infants predisposed to upper respiratory infections in a longitudinal study [16]. Despite these 
findings, a detailed description of the nasal microbiota in infants with respect to allergic 
diseases such as rhinitis and wheezing has not been studied longitudinally. In this study, we 
monitored and evaluated the dynamics of the nasal microbiota in a subcohort of infants 
belonging to the GUSTO birth cohort over seven time points. The subjects of this subcohort 
had early onset childhood rhinitis which was associated with parental atopy and atopic 
comorbidities of atopic dermatitis and wheeze [4]. Given the influential role of the 
microbiome in the pathogenesis of respiratory tract infections and atopic diseases, the 
microbiome of the infant’s airways may provide insights into the contributory or inhibitory 
role of bacteria on the manifestations of atopy.
Methods
Study Population
This case-control study recruited a subset of infants from the GUSTO birth cohort of 1,237 
Singaporean newborns [17]. GUSTO is a general population birth cohort and not at risk for 
atopy cohort. Primary objective of GUSTO study is to identify and evaluate the role of risk 
factors and determinants influencing body composition and metabolism during early 
development, and their influence on infants’ health in later childhood. Rhinitis and other 
atopic outcomes is included as a sub-study of this cohort. Briefly, mothers were recruited 
antenatally and their children were followed up with scheduled home visits at 3 weeks, 3, 6, 
9, 12, 15 months and a clinic visit at 18 months. During these seven visits, caretakers of the 
subjects were administered a questionnaire on demographic, lifestyle and symptoms of 
rhinitis and wheeze. Positive cases of rhinitis were then followed up by monthly phone calls 
to monitor rhinitis progression until a 3-month remission period was over to minimize false-
positive cases. This study was approved by the relevant institutions’ ethical review boards 
(DSRB:B/2009/584 and CIRB:2009/1024/E). Written informed consent was obtained from 
parents or legal guardians of the subjects.
There were 733/1,237 (59.3%) evaluable subjects (excluding drop-outs and those with 
missing clinical data) who completed follow up till 18 months of age (Fig 1). There were 
138 subjects who fulfilled our criteria of rhinitis by 18 months at age. Selection of rhinitis 
subjects was based on the highest number of available nasal swabs. A total of 62/138 
(44.9%) subjects that provided at least four out of the seven nasal swab samples, were then 
categorized into two groups: rhinitis without wheeze (n=28) and rhinitis with wheeze 
(n=34). Sixty controls without rhinitis or wheeze were selected with similar characteristics 
(mode of delivery, age, birth order and day-care attendance) to minimize potential selection 
bias. Controls had at least four nasal swabs and had negative responses for rhinitis and 
wheeze (as defined in section below) in the first 18 months of life.
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Case Definitions
Rhinitis was defined as having symptoms of sneezing, runny and/or blocked nose that lasted 
for at least four weeks in single or multiple episodes (each episode lasting at least two 
weeks) This definition was based on the Allergic Rhinitis and its Impact on Asthma (ARIA) 
guidelines [4]. Wheeze was defined as presence of wheeze symptoms (noisy breathing with 
a high-pitched, whistling sound heard from the chest, not the mouth). Eczema was defined 
as physician-diagnosed eczema in the first 18 months. At the 18 month visit, subjects were 
assessed via skin prick test (SPT) for the presence of allergic sensitization to a panel of food 
(milk, peanut, egg) and house dust mites allergens (Dermatophagoides pteronyssinus, 
Dermatophagoides farinae) from Greer Laboratories (Lenoir, NC, USA) and Blomia 
tropicalis (extract obtained from in-house laboratory) [18]. Wheal size of at least 3mm larger 
than the negative control (saline) was inferred as a positive reaction.
Sample Collection
Anterior nasal swabbing was carried out on infants during the visits at seven time points (3 
weeks, 3, 6, 9, 12, 15 and 18 months) using dry flocked swabs and stored in Universal 
Transport Medium (Copan Diagnostics, USA) tubes at -80°C on the same day of collection 
until analysis.
Nucleic Acid Extraction, 16S rRNA Gene Amplification and Sequencing
DNA was extracted using QIAGEN EZ1 DNA Extraction kit and QIAGEN EZ1 Advanced 
XL automated purification machine (Qiagen, Germany) according to the manufacturer’s 
instruction. Bacterial 16S rRNA gene sequences (V3-V6) were amplified and purified as 
described in Ong et al. [19]. Purified amplicons were fragmented using E220 Focused-
ultrasonicator (Covaris, USA) to yield product of an average length of 180 bases. QIAGEN 
GeneRead DNA Library Prep I Kit (QIAGEN, Germany) was used for library preparation. 
Multiplexing Sample Preparation Oligonucleotide Kit (Illumina, USA) was used to label 
DNA sequencing libraries. Multiplexed pair-end sequencing (2 x 76bp reads) was performed 
using Illumina HISEQ RAPID platform.
16S rRNA Sequencing Analysis
Samples with less than 100,000 reads were removed. Reconstruction of the original 
amplicon (V3-V6) sequences and classification of amplicon sequences followed the 
workflow described in Ong et al. [19], which is based on “Expectation Maximization 
Iterative Reconstruction of Genes from the Environment” (EMIRGE) [20]. EMIRGE-
reconstructed sequences were trimmed to the primer-amplified section and searched using 
BLAST against the complete Greengenes database (dated May, 2013; greengenes/
13_5/99_otus.fasta). Hits below predefined percent identity (97% at the species level, 94.5% 
at the genus level, 86.5% at the family level and 75% at the phylum level) were not 
considered for classification and removed. EMIRGE assigns abundance estimates to 
reconstructed sequences. Those quality-passed sequences were clustered into operational 
taxonomy units (OTUs). The relative abundance of OTUs and Shannon diversity index (SDI) 
were calculated for each sample at each taxonomic level.
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Bioinformatics Analysis
All bioinformatics analyses were performed in the R version 3.4.1 within R studio version 
1.0.136. Package “vegan” was used to plot rarefaction curves and Principal Coordinates 
Analysis (PCoA) based on Bray-Curtis distance to visualize the separation of microbiota 
profiles between groups. “Envfit” function was used to fit bacterial abundance onto 
ordination space (p<0.001, 999 permutations) to determine the microbial determinants that 
shape the bacterial community composition [21]. The Sankey plots was constructed by a 
custom C++ script (https://github.com/BetaCollins/Sankey). Spearman correlation analysis 
was done using CoNet plugin in Cytoscape as described by Hannigan et al. [22, 23]. 
Correlation heatmap and network were visualized in Graphpad Prism 7.0 and Cytoscape 
3.4.0 respectively.
Statistical Analysis
All statistical analyses were carried out using IBM Statistical Package for the Social 
Sciences (SPSS) Statistics version 22 (IBM Cooperation, New York). Univariate analysis 
(chi-square test) was used to study the demographic, lifestyle and clinical factors between 
groups. Linear mixed model and linear regression were used to evaluate the bacterial 
abundance longitudinally and at specific time points respectively, as well as to explore the 
effect of demographic factors on abundance of main bacterial groups, while adjusting for 
potential confounders. All statistical significance tests and confidence intervals were two-
sided and set at p<0.05. Geometric means were used to represent bacterial abundance and 
SDI due to non-parametric data distribution.
Results
Demographic, Lifestyle and Clinical Characteristics
The demographic, lifestyle and clinical characteristics of the population were summarized in 
Table 1. Eczema symptoms and allergen sensitization to any of the 6 tested allergens were 
more common in rhinitis groups than controls (p<0.05). Maternal history of eczema, and 
paternal history of rhinitis and eczema was also higher in rhinitis without wheeze group than 
controls (p<0.05). The use of postnatal antibiotics, Chinese/Malay ethnicity, maternal 
history of rhinitis, infant-care attendance in the first year were significantly associated with 
rhinitis with concomitant wheeze compared to control infants (p<0.05). Other demographic 
and clinical factors were not significantly different between groups.
In the clinical groups with rhinitis, the mean (± SD) onset of rhinitis symptoms was 7.1 
± 4.8 months (range 3 weeks to 18 months) and wheeze symptoms onset was 8.2 ± 4.6 
months (range 3 to 18 months).
16S rRNA Sequencing Summary
There was a total of 670 nasal swab samples collected from 122 subjects (62 cases and 60 
controls). Excluding samples with low yield of DNA concentration and low reads count, this 
yielded 620 nasal swab samples. The sequencing summary is tabulated in Table E1. The 
rarefaction curve for number of observed OTUs at family level were generated (Fig E1).
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Dynamics of Bacterial Diversity
Overall SDI was significantly lower in both rhinitis groups (without wheeze: geometric 
mean SDI=0.85; with wheeze: geometric mean SDI=0.83) compared to controls (geometric 
mean SDI=0.97, p=0.03 and 0.01 respectively) (Fig 2A). Diversity in controls increased 
(p=0.019) while diversity in infants from both rhinitis groups declined over time (without 
wheeze, p=0.028; with wheeze, p=0.025) (Fig 2B).
Maturation of the Nasal Microbiota In the First 18 Months of Life
The overall distribution of nasal microbiota down to species level is shown using Sankey 
plots (Fig 3). The Sankey plots for each clinical group are shown in Figure E2. The 
abundance of predominant phyla, family and genus are summarized in Figure 4 and Table 
E2. Abundance data down to species level were not analyzed further due to low bacterial 
identification rate.
Phyla and Family—For all the three clinical groups, the predominant phyla were 
Actinobacteria, Proteobacteria and Firmicutes, which accounted for more than 97% of the 
total nasal microbiota. Other minor phyla made up less than 2% of the whole bacterial 
community.
Higher abundance of Actinobacteria was associated with control group compared to both 
rhinitis groups till the age of 18 months (without wheeze: adj p=0.034; with wheeze: adj 
p<0.01). Corynebacteriaceae family comprised 95.1% of this phylum. Correspondingly, the 
abundance of Corynebacteriaceae was higher in controls than both rhinitis groups (without 
wheeze: adj p=0.037; with wheeze: adj p<0.01).
In contrast, higher abundance of Proteobacteria phylum was observed for the rhinitis groups 
compared to controls, but statistical significance was seen only for rhinitis with wheeze (adj 
p <0.01). At family level, Oxalobacteraceae and Moraxellaceae comprised 36.9% and 39.3% 
of this phylum respectively. However, only Oxalobacteraceae was significantly higher in 
rhinitis with wheeze than controls over time (adj p<0.01).
Firmicutes phylum did not show distinct trends longitudinally for all clinical groups. 
However, Aerococcaceae family, which comprised 67.6% of this phylum, was higher in 
rhinitis with wheeze group compared to controls (adj p <0.01). Staphylococcaceae made up 
14.8% of the Firmicute phylum and was significantly decreased in both rhinitis groups till 9 
month (adj p<0.05).
Genera—The Corynebacteriaceae, Aerococcaceae, Moraxellaceae and Staphylococcaceae 
families were made up mainly of Corynebacterium spp. (82.0%), Alloiococcus spp. (94.3%), 
Moraxella spp. (43.7%) and Staphylococcus spp. (91.1%) respectively. The trends of these 
genera in the first 18 months were similar to their corresponding families (Fig 4C). 
Janthinobacterium spp. was the only genus of Oxalobacteraceae family that was identified 
with the sequencing data processing method employed. However, the average relative 
abundance of this genus was only 0.3%.
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In summary, the relative abundance of bacteria between the three clinical groups showed 
distinct trends throughout 18 months of life. Although differences in bacteria composition 
were observed for both groups of rhinitis (with and without wheeze) compared to controls, 
the differences were more marked in the rhinitis with concomitant wheeze group. 
Furthermore, correlation analysis showed that Oxalobacteraceae family (Proteobacteria 
phylum) had direct negative interactions with Aerococcaceae family (Firmicutes phylum) 
and Corynebacteriaceae family (Actinobacteria phylum) in all three clinical groups 
throughout the first 18 months. This reinforces the results of our longitudinal analysis (Fig 
4) that a distinct pattern of microbial abundance of the major bacterial groups was associated 
with the clinical outcomes; where high abundance of Corynebacteriaceae and 
Staphylococcaceae, and low abundance of Oxalobacteraceae and Aerococcaceae were 
associated with controls and the reverse pattern of abundance for rhinitis and wheeze (Fig 
E3). There was lower abundance of the Corynebacteriaceae and showed little fluctuation 
throughout the 18 month period in both rhinitis groups (with and without wheeze) compared 
to controls.
Multivariate Analysis of Nasal Microbial Community Composition
To investigate the differences in community composition between clinical groups, PCoA 
was plotted at seven time points (Fig 5). The five bacterial groups (Corynebacteriaceae, 
Oxalobacteraceae, Moraxellaceae, Aerococcaceae and Staphylococcaceae families) together 
explained an average of 54.6% (range: 49.87%-57.69%) of the overall variability in the 
microbiota composition. Distinct bacterial community composition was seen between two 
groups of rhinitis and controls at 3 weeks and 3 months. At these time points, 
Corynebacteriaceae and Staphylococcaceae significantly influenced controls whilst 
Oxalobacteraceae and Aerococcaceae shaped the rhinitis groups (p<0.001). The clusters 
between groups became less distinct from 6 months onwards. Moraxellaceae drove bacterial 
composition of rhinitis groups at this time point (p<0.001). The microbial communities after 
9 months showed an obvious shift and disappearing of distinct clusters between clinical 
groups. Of note, Corynebacteriaceae remained the key bacterial drivers of bacterial 
community in controls till 12 months (p<0.001).
Influence of Demographic and Clinical Determinants on Establishment of the Main Nasal 
Bacterial Groups
Linear regression was employed to evaluate the effect of demographic and clinical factors on 
the overall dynamic establishment of the five main bacterial families (Fig E4). Caesarean-
delivery and male gender were associated with higher abundance of Aerococcaceae and 
lower abundance of Staphylococcaceae (adj p<0.05). Presence of siblings and infant care 
attendance were associated with lower colonization of Corynebacteriaceae, and higher 
carriage of Oxalobacteraceae and Moraxellaceae (adj p<0.05). Other factors (pre-term, use 
of intrapartum antibiotic prophylaxis and postnatal antibiotics, family history of atopic 
diseases and exclusive breastfeeding pattern) did not show significant associations.
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Discussion
The longitudinal design of this study with serial sampling over seven time points describes 
the dynamic changes and provides valuable snapshots of the succession of the nasal 
microbiota in early childhood. We observed distinct differences in the profiles of microbiota 
of infants who developed rhinitis, especially in those who also had concomitant wheeze in 
the first 18 months of life compared to healthy controls. As these differences were present 
from the earliest time points (3 weeks and 3 months of age), and before the onset of clinical 
symptoms in the majority of subjects, our findings strongly suggest a role of the nasal 
microbiome in the development of respiratory disease.
Nasal Microbial Diversity
The nasal microbial diversity increased with age in the controls, whilst the rhinitis groups 
(with or without concomitant wheeze) was reversed with decreasing trends with age. Other 
cross-sectional studies in infants and young children with respiratory disorders such as 
asthma, allergic rhinitis and acute respiratory infection, have described similar findings [24–
26].
Distinct Bacterial Profiles Between Disease Groups and Healthy
The three dominating phyla of the infant nasal microbiome were Actinobacteria, 
Proteobacteria and Firmicutes which is consistent with other longitudinal studies in children 
[13, 16].
Both the rhinitis (without and with wheeze) groups had decreased abundance of 
Corynebacteriaceae family (Actinobacteria phylum) compared to controls. Other studies 
have also shown reduced abundance of Corynebacteriaceae with other respiratory conditions 
such as acute otitis media and wheezing [13, 27]. Of interest is the finding that 
Corynebacterium accolens from the human nasal mucosa releases antibacterial free fatty 
acid from human triacylglycerols [28]. Taken together, these findings suggest that a high 
abundance of Corynebacteriaceae confers protection by inhibiting other potentially 
pathogenic bacteria against respiratory diseases in infants.
In contrast to Corynebacteriaceae, there was higher abundance of Proteobacteria in those 
with rhinitis and concomitant wheeze compared to controls. This observation was consistent 
with other studies that reported its association with wheezing respiratory disorders [29]. 
Although there have not been other reports of Oxalobacteriaceae family in association with 
wheeze in infants specifically, its relation with asthma in adults has been reported [30]. Our 
current study in infants strengthens the possibility that Oxalobacteraceae may contribute to 
wheezing disorders.
The evidence that Moraxella spp. (Moraxellaceae family) influences subsequent respiratory 
illness appears to vary between studies. Several studies have shown that Moraxella spp. was 
associated with an increased risk of pneumonia in children in their first 3 years of life [31]. 
On the other hand, it has also been shown to be a part of a commensal bacterial community 
in the first 2 years of life and protects against subsequent respiratory infection [32]. In our 
study, there was no difference in abundance of Moraxella spp. between clinical groups 
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longitudinally but it was significantly increased in both rhinitis groups at the 6 month time 
point.
Similar to Oxalobacteraceae family, the abundance of Aerococcaceae family (Firmicutes 
phylum) was significantly higher with the rhinitis and concomitant wheeze group compared 
to controls. As in all clinical groups, Aerococcaceae colonization appears later in age (6 
months and beyond) compared to Oxalobacteraceae and Corynebacteriaceae. This 
observation is consistent with previous reports in children studied longitudinally from 1 till 
24 months [32, 33]. The microbials belonging to the Aerococcaceae were further identified 
to belong to the Alloiococcus spp. Although this genus appeared to be strongly associated 
with rhinitis and wheeze in our study, other studies have shown the contrary, in that lower 
abundance of Alloiococcus spp. during infancy was associated with higher numbers of acute 
respiratory infections [13]. Little is known of its role in early nasal microbial colonization. 
Alloiococcus is a Gram-positive genus with only one known species, Alloiococcus otitidis 
(A. otitidis) [34]. This species is frequently detected in the outer/middle ear canal and 
nasopharyngeal of children with acute otitis media. Studies from Japan found that 
nasopharyngeal colonization of A. otitidis is increased in otitis-prone children compared to 
that in non-otitis-prone children [35, 36]. This organism is also shown to induce local 
immune response in the middle ear as a pathogen [37, 38].
Staphylococcaceae family (Firmicutes phylum) differ between clinical groups longitudinally 
till 9 months, and its abundance was significantly higher at early time points (3 week and 3 
month) in controls compared to the rhinitis groups. This was strengthened by PCoA at 3 
week and 3 month, Staphylococcaceae is, therefore, a feature of early colonization in 
healthy individuals before its declines in later infancy, and this is supported by other studies 
in healthy children aged below 18 months of age [13, 33]. Although cutaneous colonization 
of Staphylococcus spp., particularly Staphylococcus aureus is associated with atopic eczema 
[39], our longitudinal analysis did not show any association between eczema and 
colonization of nasal Staphylococcus spp. (data not shown).
Our data indicate that the succession of nasal bacterial over the first 18 months of life 
influence the susceptibility to wheeze. We observed that high carriage of Oxalobacteraceae 
and low abundance of Corynebacterium spp. (Corynebacteriacecae family) and 
Staphylococcaceae in the early time points (till 9 months) appeared to encourage the early 
colonization and growth of Alloiococcus spp. (Aerococcaceae family) at an accelerated rate 
in subjects with wheeze compared to controls. Thus, the initial establishment of 
Oxalobacteraceae rather than Corynebacterium spp. might be a predictive marker of 
transition to the subsequent increase in abundance of Alloiococcus spp. Of note is the 
‘graded’ degree of dysbiosis between the rhinitis alone and rhinitis with concomitant wheeze 
groups, with the rhinitis with wheeze group showing the more extreme difference from 
controls. It is tempting to speculate that larger deviation from ‘normal’ microbial 
establishment in the airway is required to predispose wheeze in infancy. Our findings are 
supported by Bosch et al. who reported an accelerated maturation of microbiota in children 
with more than two respiratory tract infection episodes per year compared to controls with 
less than two episodes [16].
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Determinants of Establishment of Nasal Microbiota
This study found that male gender, presence of siblings, Caesarean delivery and infant-care 
attendance influenced the establishment and maturation of the nasal microbiome. These 
factors could be the determinants for dysbiotic nasal microbiota that could predispose to 
rhinitis and wheeze later in life.
The presence of siblings and daycare attendance was associated with lower abundance of 
Corynebacteriaceae and higher abundance of Oxalobacteraceae and Moraxellaceae. This 
interaction with other young children has also been shown to be related to frequent wheezing 
at the age of 2 years compared to children with little or no exposure [40]. An Australian 
study by Teo et al., showed that significantly higher relative abundances of Moraxella spp. 
and lower relative abundances of Corynebacterium spp. in infants attending day care 
compared to those at home [13]. A cross-sectional American study showed that infants with 
siblings were more likely be dominated by Moraxella than a Corynebacterium while 
opposite pattern was observed in those without siblings [41]. Whether the increased 
exposure to respiratory viruses or its influence on the establishment of the nasal microbiome 
through the interaction with other young children plays a more important role in the 
development of wheezing illness in early life will require further study.
Our results also showed that male gender and delivery by Caesarean section was associated 
with a more ‘dysbiotic’ nasal microbial profile with higher abundance of Aerococcaceae and 
lower abundance of Staphylococcaceae. Although not observed in other studies, the mode of 
delivery did impact on the succession of nasal microbiome in early life [16]. A birth cohort 
study up to 6 months led by Bosch et al. showed that children born by Caesarean section had 
a higher abundance of Staphylococcus aureus than vaginally born children, even though this 
trend was most prominent at the early time points. In relation to gender, male gender has 
been shown to be a universal risk factor for respiratory disorders such as rhinitis, wheeze and 
asthma in early childhood in most populations published and not confined to this cohort [42, 
43]. This may arise from gender differences in lung airway anatomy and maturation [44]. 
The airways in males have been found to be structurally narrower than females and this 
anatomical difference may contribute to the higher prevalence of wheezing disorders in the 
male [45, 46]. However, there are other gender related differences that may explain the 
gender differences in nasal bacterial colonization that was observed in our cohort. Firstly, the 
delay in pulmonary surfactant in the male fetal lung compared to females [47, 48] may 
contribute to the pattern of early microbial colonization. Surfactant proteins have the ability 
to aggregate and control the clearance of bacteria through binding and neutralization by 
acting as opsonin [49–51]. Secondly, the innate and adaptive immune responses of male 
infants are also weaker than females, and this difference may influence differential 
colonization of the nasal mucosa [52–54].
Our study did not show a significant impact of intrapartum antibiotic prophylaxis or post-
natal antibiotic on the nasal microbiome. Other studies in infants with respiratory tract 
infection and acute otitis media have shown a negative association between antibiotic usage 
and Corynebacteriaceae carriage [16, 27]. These differences between studies may in part be 
explained by the different collection sites of our study (anterior nares) and other studies 
(nasopharyngeal).
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Limitations and Conclusion
The limitation in this study is that the sampling area is the anterior nares. Several studies 
have highlighted the variation in bacterial composition between different sites of respiratory 
tract [55–58]. Moreover, the impact of virus was not analyzed in our study which deserves 
further investigation. We were also unable to analyze all the bacteria groups down to species 
level. Future studies involving metagenomics sequencing may provide more precise 
identification of bacteria and may also provide information on viruses.
Despite these limitations, our longitudinal birth cohort with dense serial sampling support 
the hypothesis that distinct profiles of the nasal microbiota in the first 18 months of life 
impact on the development of rhinitis and wheezing in later infancy. Our GUSTO follow up 
data showed that 20% of infants with rhinitis persisted to have rhinitis at the age 5 years, 
whilst controls remained rhinitis free (data not shown), indicating that rhinitis status at 18 
months is a predictor for rhinitis status at 5 years. Further work to verify these findings and 
its impact on subsequent allergic rhinitis and asthma in later childhood will provide 
important insights into the role of the nasal microbiome in these disorders. These are 
important steps towards developing novel strategies for the treatment and management of 
these disorders.
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Capsule Summary
The nasal microbiome in the first 18 months of life is involved in the development of 
rhinitis and wheeze in early life. A decrease in Corynebacteriaceae and 
Staphylococcaceae, and increase in Oxalobacteraceae and Aerococcaceae of the anterior 
nares are associated with early onset rhinitis and wheeze.
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Clinical Implications
Research into the mechanisms behind longitudinal variation in the respiratory 
microbiome may pave the way for the prevention and treatment of early onset rhinitis and 
wheezing disorders.
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Figure 1. 
Flowchart of Subject Selection.
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Figure 2. 
Microbial diversity of the three clinical groups. (A) Overall Shannon Diversity combining 
all seven time-points from 3 weeks till 18 months; (B) Shannon diversity of the three clinical 
groups by time points. Max, min, 25th percentile, 75th percentile and geometric mean of 
relative abundance were used for box and whisker plot.
* denotes significance at p<0.05 between groups.
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Figure 3. 
Sankey plot representing the overall nasal bacterial composition and their corresponding 
average abundance for three clinical groups. Each colour represents different taxonomy 
classification levels. The arithmetic mean of relative abundance is inserted below each 
microbial group.
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Figure 4. 
Bacterial abundance of major (A) Phyla, (B) Family and (C) Genus of the three clinical 
groups by time points. Data presented as geometric mean of relative abundance. Adjusted p 
values denotes significant difference of bacterial relative abundance between rhinitis and 
control groups using linear mixed model analysis and linear regression after adjusting for 
confounders (gender, family history of respiratory disease, presence of siblings, mode of 
delivery, use of intrapartum antibiotic prophylaxis and postnatal antibiotics and 
breastfeeding pattern).
* denotes significant difference at p<0.05 between rhinitis with wheeze and control group at 
specific time point.
** denotes significant difference p<0.05 between both rhinitis groups and control group at 
specific time point.
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Figure 5. 
Principal coordinates analysis (PCoA) based on Bray–Curtis dissimilarity between nasal 
microbiome profiles (Family level) for the three clinical groups at various time-points. (A) 3 
week; (B) 3 month; (C) 6 month; (D) 9 month; (E) 12 month; (F) 15 month and (G) 18 
month. Arrow shows the directions from the origin for which clusters have significant 
abundances for the bacterial groups (p<0.001, 999 permutations) and its length is 
proportional to the correlation between ordination and the bacterial groups.
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